Inspection Record

Dufort & Lavigne Ltée — Health Canada Inspection Findings

Health CanadaInspected 2021-05-28 5 findingsStability and storageOther quality systemEquipment and facilityValidation and qualification

View the regulator's official source The source document is always the basis for judgement.

Findings

1Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

2Other quality system

The recorded information or details were inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

3Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

4Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

5Validation and qualification

The qualification and/or verification of utilities and/or support systems was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-05-28. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Dufort & Lavigne Ltée company profile — full history Health Canada documents, 2021 Go to Findings search